Acetaminophen as Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Objective: Although the pathogenesis of schizophrenia is still uncertain, a variety of predisposing mechanisms have been implicated including inflammatory cascades. The present study was conducted to investigate the effectiveness of acetaminophen as a cyclooxygenase inhibitor in treating patients wi...
Main Authors: | Somaye Arabzadeh, Atefeh Zeinoddini, Seyed-Ali Mostafavi, Mehdi Hamedi, Abolfazl Ehyaii, Ali Ghaleiha, Arefeh Zeinoddini, Shahin Akhondzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2018-02-01
|
Series: | Iranian Journal of Psychiatry |
Subjects: | |
Online Access: | https://ijps.tums.ac.ir/index.php/ijps/article/view/1320 |
Similar Items
-
Population Pharmacodynamic Models of Risperidone on PANSS Total Scores and Prolactin Levels in Schizophrenia
by: Zhiwei Huang, et al.
Published: (2024-01-01) -
Relationship of Neuropeptide S with Clinical and Metabolic Parameters of Patients during Rehabilitation Therapy for Schizophrenia
by: Agnieszka Markiewicz-Gospodarek, et al.
Published: (2022-06-01) -
Prevalence of depression in persons with schizophrenia – A cross-sectional study from a tertiary psychiatric hospital
by: Reshma Susan Mathew, et al.
Published: (2023-06-01) -
Acetaminophen overdose associated with double serum concentration peaks
by: Cristian Papazoglu, et al.
Published: (2015-12-01) -
Suicidal tendencies in Schizophrenia patients
by: A. Pascariu, et al.
Published: (2022-06-01)